{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-264667","form_type":"8-K","ticker":"HNGE","cik":"0001673743","company_name":"Hinge Health, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.110260+00:00","generated_at":"2026-05-17T00:39:08.082657+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Hinge Health Q3 revenue $154.2M (+53% YoY); raises FY 2025 guidance","bullets":["Revenue $154.2M vs $100.6M in Q3 2024, +53% YoY; GAAP gross margin 82% vs 79%.","Non-GAAP income from operations $30.4M vs loss of $3.7M a year ago; free cash flow $81.3M.","Lifetime members surpassed 1.5M; client count up 25% to 2,560; LTM billings $624.2M (+50%).","FY 2025 revenue guidance raised to $572M-$574M (47% YoY growth at midpoint); non-GAAP op income $106M-$108M.","Q4 2025 revenue guided $155M-$157M (+33% YoY at midpoint); non-GAAP op income $34M-$36M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-264667","json":"https://secwatch.observer/filing/0001193125-25-264667.json","markdown":"https://secwatch.observer/filing/0001193125-25-264667.md","text":"https://secwatch.observer/filing/0001193125-25-264667.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1673743/000119312525264667/0001193125-25-264667-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1673743/000119312525264667/hnge-20251104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:39:08.082657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}